The Impact of Hydration and Other Strategies in prevention of Contrast-Induced Nephropathy
DOI:
https://doi.org/10.12775/QS.2024.15.51740Keywords
Contrast-induced nephropathy, hydration, CIN, risk factors, prevention, contrast media, acute kidney injury, renal dysfunctionAbstract
Introduction and purpose Contrast-induced nephropathy (CIN) remains a significant concern in clinical practice, particularly among patients undergoing contrast-enhanced imaging or interventional procedures. Characterized by an acute decline in renal function following exposure to contrast media, CIN not only poses substantial morbidity and mortality risks but also presents challenges in patient management and healthcare resource utilization. Despite extensive research efforts, the precise pathophysiology of CIN remains incompletely understood, with multifactorial mechanisms involving renal ischemia, oxidative stress, and direct tubular toxicity implicated in its development. This review explores the impact of hydration and other prophylactic strategies on the prevention of CIN. Numerous studies have demonstrated the effectiveness of various hydration protocols, including isotonic saline and bicarbonate solutions, in reducing the incidence of CIN. Additionally, the review evaluates the efficacy of pharmacological agents such as N-acetylcysteine, statins, and ascorbic acid, as well as emerging techniques like remote ischemic preconditioning.
References
Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. American Journal of Kidney Diseases. 2002;39(5):930–6.
Chang CF, Lin CC. Current concepts of contrast-induced nephropathy: A brief review. Vol. 76, Journal of the Chinese Medical Association. 2013. p. 673–81.
Thomsen HS, Morcos SK. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Vol. 76, British Journal of Radiology. 2003. p. 513–8.
Toprak O, Cirit M. Risk factors and therapy strategies for contrast-induced nephropathy. Vol. 28, Renal Failure. 2006. p. 365–81.
Yoon HJ, Kim H, Lee JP, Choi SW, Cho HO, Shin HW, et al. The efficacy of the cystatin C based glomerular filtration rate in the estimation of safe contrast media volume. Korean Circ J. 2013;43(9):622–7.
Pucelikova T, Dangas G, Mehran R. Contrast-induced nephropathy. Vol. 71, Catheterization and Cardiovascular Interventions. 2008. p. 62–72.
Isaka Y, Hayashi H, Aonuma K, Horio M, Terada Y, Doi K, et al. Guideline on the Use of Iodinated Contrast Media in Patients With Kidney Disease 2018. Circulation Journal [Internet]. 2019 Nov 25;83(12):2572–607. Available from: https://www.jstage.jst.go.jp/article/circj/83/12/83_CJ-19-0783/_article
Rudnick MiR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial. Vol. 47, Kidney International. 1995.
Gupta S. Contrast-Induced Nephropathy: Current practice. Journal of Urology & Nephrology Studies. 2018 Jun 5;1(1).
Kalyesubula R, Bagasha P, Perazella MA. ACE-I/ARB therapy prior to contrast exposure: What should the clinician do? Vol. 2014, BioMed Research International. 2014.
Ellis JH, Cohan RH. Reducing the risk of contrast-induced nephropathy: A perspective on the controversies. Vol. 192, American Journal of Roentgenology. 2009. p. 1544–9.
Newhouse JH, Kho D, Rao QA, Starren J. Frequency of serum creatinine changes in the absence of iodinated contrast material: Implications for studies of contrast nephrotoxicity. American Journal of Roentgenology. 2008;191(2):376–82.
Morcos SK. Contrast-induced nephropathy: are there differences between low osmolar and iso-osmolar iodinated contrast media? Vol. 64, Clinical Radiology. 2009. p. 468–72.
Goldfarb S, McCullough PA, McDermott J, Gay SB. Contrast-induced acute kidney injury: Specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology. Vol. 84, Mayo Clinic Proceedings. Elsevier Ltd; 2009. p. 170–9.
Schweiger MJ, Chambers CE, Davidson CJ, Zhang S, Blankenship J, Bhalla NP, et al. Prevention of contrast induced nephropathy: Recommendations for the high risk patient undergoing cardiovascular procedures. Vol. 69, Catheterization and Cardiovascular Interventions. Wiley-Liss Inc.; 2007. p. 135–40.
Jurado-Román A, Hernández-Hernández F, García-Tejada J, Granda-Nistal C, Molina J, Velázquez M, et al. Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention. American Journal of Cardiology. 2015 May 1;115(9):1174–8.
Feng Y, Huang X, Li L, Chen Z. N-acetylcysteine versus ascorbic acid or N-acetylcysteine plus ascorbic acid in preventing contrast-induced nephropathy: A meta-analysis. Nephrology. 2018 Jun 1;23(6):530–8.
Hoffmann U, Fischereder M, Krüger B, Drobnik W, Krämer BK. The Value of N-Acetylcysteine in the Prevention of Radiocontrast Agent-Induced Nephropathy Seems Questionable. Journal of the American Society of Nephrology. 2004 Feb;15(2):407–10.
Brar SS, Yuh-Jer Shen A, Jorgensen MB, Kotlewski A, Aharonian VJ, Desai N, et al. Sodium Bicarbonate vs Sodium Chloride for the Prevention of Contrast Medium-Induced Nephropathy in Patients Undergoing Coronary Angiography A Randomized Trial [Internet]. Available from: http://jama.jamanetwork.com/
Merten GJ, Patrick Burgess W, Gray L V, Holleman JH, Roush TS, Kowalchuk GJ, et al. Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate A Randomized Controlled Trial [Internet]. Available from: http://jama.jamanetwork.com/
Zhang B, Liang L, Chen W, Liang C, Zhang S. The efficacy of sodium bicarbonate in preventing contrast-induced nephropathy in patients with pre-existing renal insufficiency: A meta-analysis. BMJ Open. 2015;5(3).
Ferrario F, Barone MT, Landoni G, Genderini A, Heidemperger M, Trezzi M, et al. Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy - A randomized controlled study. Nephrology Dialysis Transplantation. 2009 Oct;24(10):3103–7.
Spargias K, Alexopoulos E, Kyrzopoulos S, Iacovis P, Greenwood DC, Manginas A, et al. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation. 2004 Nov 2;110(18):2837–42.
Pappy R, Stavrakis S, Hennebry TA, Abu-Fadel MS. Effect of statin therapy on contrast-induced nephropathy after coronary angiography: A meta-analysis. Int J Cardiol. 2011 Sep 15;151(3):348–53.
Zhao JL, Yang YJ, Zhang Y hui, You SJ, Wu YJ, Gao RL. Effect of statins on contrast-induced nephropathy in patients with acute myocardial infarction treated with primary angioplasty. Int J Cardiol. 2008 Jun 6;126(3):435–6.
Nadkarni GN, Konstantinidis I, Patel A, Yacoub R, Kumbala D, Patel RAG, et al. Trimetazidine decreases risk of contrast-induced nephropathy in patients with chronic kidney disease: A meta-analysis of randomized controlled trials. J Cardiovasc Pharmacol Ther. 2015 Nov 1;20(6):539–46.
Spargias K, Adreanides E, Demerouti E, Gkouziouta A, Manginas A, Pavlides G, et al. Iloprost prevents contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation. 2009 Nov;120(18):1793–9.
gleeson-bulugahapitiya-2012-contrast-induced-nephropathy-2.
Vogt B, Ferrari P, Schönholzer C, Marti HP, Mohaupt M, Wiederkehr M, et al. Prophylactic Hemodialysis after Radiocontrast Media in Patients with Renal Insufficiency is Potentially Harmful.
Vogt B, Ferrari P, Schönholzer C, Marti HP, Mohaupt M, Wiederkehr M, et al. Prophylactic Hemodialysis after Radiocontrast Media in Patients with Renal Insufficiency is Potentially Harmful.
Marenzi G, Marana I, Lauri G, Assanelli E, Grazi M, Campodonico J, et al. The Prevention of Radiocontrast-Agent-Induced Nephropathy by Hemofiltration [Internet]. Vol. 14, n engl j med. 2003. Available from: www.nejm.org
American College of Radiology. Committee on Drugs and Contrast Media. ACR manual on contrast media. 125 p.
Katzberg RW, Lamba R. Contrast-Induced Nephropathy after Intravenous Administration: Fact or Fiction? Vol. 47, Radiologic Clinics of North America. 2009. p. 789–800.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Joanna Wojtania, Michał Łepik, Zofia Uszok, Krzysztof Rosiak, Kacper Płeska, Kacper Reguła, Kamil Waloch, Szymon Piaszczyński, Andrzej Czajka, Bartłomiej Szymański
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 122
Number of citations: 0